The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
Official Title: 18F-Fluorodeoxyglucose Positron Emission Tomography in Oncology and Neurology
Study ID: NCT01180751
Brief Summary: This clinical trial is being conducted to study the use of a radioactive glucose tracer as an imaging test \[Positron Emission Tomography (PET)scan\] in adults who have or are suspected of having cancer and in another group of adults to assess for neurologic conditions.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Great West Life PET/CT Centre, Winnipeg, Manitoba, Canada
Name: Daniel P Levin, BSc,MD,FRCPC
Affiliation: Winnipeg Regional Health Authority
Role: PRINCIPAL_INVESTIGATOR